| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatectomy | 32 | 2024 | 1824 | 3.010 |
Why?
|
| Prostatic Neoplasms | 57 | 2024 | 11118 | 2.830 |
Why?
|
| Laparoscopy | 19 | 2024 | 2035 | 2.550 |
Why?
|
| Prostate | 21 | 2024 | 1770 | 2.320 |
Why?
|
| Intermediate Filament Proteins | 59 | 1994 | 262 | 2.130 |
Why?
|
| Ultrasonography, Interventional | 5 | 2021 | 1495 | 1.420 |
Why?
|
| Urinary Bladder Neoplasms | 11 | 2024 | 2223 | 1.320 |
Why?
|
| Cystectomy | 8 | 2024 | 634 | 1.160 |
Why?
|
| Ureteral Obstruction | 3 | 2024 | 293 | 1.000 |
Why?
|
| Neuroglia | 52 | 1992 | 955 | 0.900 |
Why?
|
| Carcinoma, Renal Cell | 9 | 2024 | 3163 | 0.900 |
Why?
|
| Spinal Cord | 39 | 1992 | 1818 | 0.890 |
Why?
|
| Glial Fibrillary Acidic Protein | 51 | 1992 | 552 | 0.860 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 2 | 2021 | 187 | 0.800 |
Why?
|
| Kidney Neoplasms | 9 | 2024 | 4248 | 0.770 |
Why?
|
| Astrocytes | 38 | 1992 | 1345 | 0.700 |
Why?
|
| Neurofilament Proteins | 45 | 1995 | 336 | 0.690 |
Why?
|
| Surgical Mesh | 3 | 2009 | 310 | 0.690 |
Why?
|
| Cytoskeleton | 29 | 1990 | 1170 | 0.650 |
Why?
|
| Kidney Pelvis | 3 | 2024 | 186 | 0.640 |
Why?
|
| Nerve Tissue Proteins | 63 | 1995 | 4414 | 0.640 |
Why?
|
| Brain Chemistry | 19 | 1993 | 959 | 0.560 |
Why?
|
| Fluorescent Antibody Technique | 79 | 1993 | 2469 | 0.560 |
Why?
|
| Office Visits | 1 | 2021 | 595 | 0.550 |
Why?
|
| Robotics | 1 | 2023 | 819 | 0.540 |
Why?
|
| Neurofibrils | 14 | 1984 | 75 | 0.540 |
Why?
|
| Paclitaxel | 3 | 2023 | 1732 | 0.540 |
Why?
|
| Intermediate Filaments | 14 | 1994 | 172 | 0.530 |
Why?
|
| Watchful Waiting | 4 | 2023 | 491 | 0.530 |
Why?
|
| Kidney | 9 | 2023 | 7049 | 0.530 |
Why?
|
| Hernia, Inguinal | 3 | 2009 | 220 | 0.480 |
Why?
|
| Prostate-Specific Antigen | 13 | 2024 | 2469 | 0.440 |
Why?
|
| Carcinoma, Transitional Cell | 4 | 2023 | 782 | 0.430 |
Why?
|
| Axons | 21 | 1992 | 1674 | 0.410 |
Why?
|
| Ganglia, Spinal | 10 | 1992 | 526 | 0.400 |
Why?
|
| Rats, Inbred Strains | 40 | 1992 | 2089 | 0.390 |
Why?
|
| Neoplasm Invasiveness | 9 | 2024 | 3589 | 0.380 |
Why?
|
| Wallerian Degeneration | 10 | 1993 | 68 | 0.380 |
Why?
|
| Male | 116 | 2024 | 360736 | 0.370 |
Why?
|
| Neoplasm Recurrence, Local | 10 | 2024 | 9277 | 0.370 |
Why?
|
| Nerve Regeneration | 11 | 1993 | 795 | 0.360 |
Why?
|
| Rats | 103 | 1994 | 23742 | 0.350 |
Why?
|
| Retrospective Studies | 32 | 2024 | 80582 | 0.350 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2024 | 36423 | 0.340 |
Why?
|
| Sciatic Nerve | 11 | 1993 | 616 | 0.340 |
Why?
|
| Chyle | 1 | 2009 | 19 | 0.330 |
Why?
|
| Biopsy | 11 | 2023 | 6766 | 0.330 |
Why?
|
| Pheochromocytoma | 2 | 2011 | 328 | 0.320 |
Why?
|
| Laminin | 12 | 1993 | 408 | 0.320 |
Why?
|
| Adrenalectomy | 1 | 2011 | 346 | 0.320 |
Why?
|
| Nerve Degeneration | 11 | 1990 | 748 | 0.310 |
Why?
|
| Adenocarcinoma | 9 | 2021 | 6339 | 0.310 |
Why?
|
| Middle Aged | 64 | 2024 | 220826 | 0.310 |
Why?
|
| Desmin | 7 | 1989 | 99 | 0.300 |
Why?
|
| Neoplasm Staging | 11 | 2024 | 11106 | 0.300 |
Why?
|
| Humans | 141 | 2024 | 761423 | 0.290 |
Why?
|
| Fistula | 1 | 2009 | 212 | 0.290 |
Why?
|
| Optic Nerve | 14 | 1992 | 572 | 0.280 |
Why?
|
| Nephrectomy | 5 | 2024 | 937 | 0.280 |
Why?
|
| Aged | 51 | 2024 | 169235 | 0.280 |
Why?
|
| Cerebellum | 20 | 1990 | 1500 | 0.270 |
Why?
|
| Molecular Weight | 28 | 1989 | 2188 | 0.270 |
Why?
|
| Carrier Proteins | 12 | 1993 | 4936 | 0.260 |
Why?
|
| Peripheral Nerves | 7 | 2020 | 479 | 0.260 |
Why?
|
| BCG Vaccine | 2 | 2024 | 369 | 0.260 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2011 | 732 | 0.260 |
Why?
|
| Epitopes | 16 | 1992 | 2507 | 0.260 |
Why?
|
| Muscles | 5 | 2023 | 1576 | 0.250 |
Why?
|
| Hyaluronic Acid | 4 | 1993 | 482 | 0.250 |
Why?
|
| Testis | 2 | 2018 | 794 | 0.240 |
Why?
|
| Hematuria | 2 | 2011 | 233 | 0.240 |
Why?
|
| Urologic Surgical Procedures | 2 | 2024 | 298 | 0.230 |
Why?
|
| Neoplastic Cells, Circulating | 3 | 2018 | 946 | 0.220 |
Why?
|
| Early Detection of Cancer | 4 | 2023 | 3201 | 0.210 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 1993 | 141 | 0.210 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2004 | 188 | 0.210 |
Why?
|
| Kidney Transplantation | 2 | 2009 | 4234 | 0.210 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2024 | 350 | 0.200 |
Why?
|
| Treatment Outcome | 19 | 2024 | 64651 | 0.200 |
Why?
|
| Neurons | 25 | 2008 | 9462 | 0.200 |
Why?
|
| Autonomic Nervous System | 4 | 2024 | 701 | 0.200 |
Why?
|
| Central Nervous System | 6 | 1987 | 1337 | 0.200 |
Why?
|
| Cattle | 30 | 1987 | 3848 | 0.200 |
Why?
|
| Transurethral Resection of Prostate | 1 | 2022 | 79 | 0.190 |
Why?
|
| Kidney Diseases | 2 | 2010 | 2092 | 0.190 |
Why?
|
| Vimentin | 15 | 1989 | 255 | 0.190 |
Why?
|
| Tuberculosis, Male Genital | 2 | 2018 | 6 | 0.190 |
Why?
|
| Brain | 39 | 1995 | 27107 | 0.190 |
Why?
|
| Diagnostic Imaging | 4 | 2015 | 3530 | 0.180 |
Why?
|
| Muscle Proteins | 8 | 1982 | 1154 | 0.180 |
Why?
|
| Urinary Bladder | 4 | 2023 | 1152 | 0.180 |
Why?
|
| Animals | 159 | 2015 | 168441 | 0.180 |
Why?
|
| Immune Sera | 15 | 1984 | 613 | 0.180 |
Why?
|
| Neurons, Afferent | 6 | 1994 | 498 | 0.180 |
Why?
|
| Kidney Calculi | 1 | 2004 | 463 | 0.180 |
Why?
|
| Perineum | 1 | 2021 | 208 | 0.170 |
Why?
|
| Peritoneum | 1 | 2021 | 225 | 0.170 |
Why?
|
| Antibodies, Monoclonal | 23 | 1992 | 9179 | 0.170 |
Why?
|
| Brachytherapy | 2 | 2022 | 1223 | 0.170 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2019 | 40 | 0.170 |
Why?
|
| Prognosis | 13 | 2024 | 29620 | 0.170 |
Why?
|
| Retina | 10 | 1991 | 2658 | 0.170 |
Why?
|
| Nerve Tissue | 3 | 1991 | 78 | 0.170 |
Why?
|
| Motor Neurons | 8 | 1994 | 870 | 0.160 |
Why?
|
| Spermatocele | 1 | 2018 | 10 | 0.160 |
Why?
|
| Kallikreins | 1 | 2020 | 220 | 0.160 |
Why?
|
| Urethra | 4 | 2022 | 405 | 0.160 |
Why?
|
| Antibody Specificity | 5 | 1987 | 1060 | 0.150 |
Why?
|
| Varicocele | 1 | 2018 | 75 | 0.150 |
Why?
|
| Orchitis | 1 | 2018 | 35 | 0.150 |
Why?
|
| Epididymitis | 1 | 2018 | 37 | 0.150 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2022 | 517 | 0.150 |
Why?
|
| Immunoenzyme Techniques | 15 | 1990 | 1706 | 0.150 |
Why?
|
| Receptors, Androgen | 4 | 2018 | 1079 | 0.150 |
Why?
|
| Adult | 29 | 2024 | 221148 | 0.150 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 19 | 1987 | 1746 | 0.150 |
Why?
|
| Combined Modality Therapy | 4 | 2024 | 8529 | 0.150 |
Why?
|
| Monitoring, Intraoperative | 2 | 2024 | 942 | 0.140 |
Why?
|
| Diagnosis, Differential | 9 | 2022 | 12970 | 0.140 |
Why?
|
| Cisplatin | 1 | 2023 | 1650 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 8 | 2021 | 6479 | 0.140 |
Why?
|
| Incidental Findings | 2 | 2019 | 697 | 0.140 |
Why?
|
| Oxides | 2 | 2009 | 401 | 0.140 |
Why?
|
| Prostheses and Implants | 1 | 2004 | 1272 | 0.140 |
Why?
|
| Goldfish | 3 | 1992 | 65 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 11740 | 0.140 |
Why?
|
| Medical Oncology | 1 | 2008 | 2321 | 0.130 |
Why?
|
| Androstenes | 1 | 2018 | 181 | 0.130 |
Why?
|
| Nerve Fibers | 8 | 1994 | 708 | 0.130 |
Why?
|
| Histocytochemistry | 16 | 1987 | 698 | 0.130 |
Why?
|
| Extracellular Matrix | 3 | 1993 | 1725 | 0.130 |
Why?
|
| HLA Antigens | 1 | 2021 | 1371 | 0.130 |
Why?
|
| Kuru | 2 | 1985 | 4 | 0.130 |
Why?
|
| Penile Diseases | 1 | 1996 | 45 | 0.130 |
Why?
|
| Respiratory Mechanics | 1 | 2019 | 699 | 0.130 |
Why?
|
| Ureter | 2 | 2004 | 367 | 0.130 |
Why?
|
| Mycobacterium Infections | 1 | 1996 | 122 | 0.120 |
Why?
|
| Chickens | 11 | 1987 | 859 | 0.120 |
Why?
|
| RNA, Neoplasm | 1 | 2018 | 750 | 0.120 |
Why?
|
| Disease-Free Survival | 7 | 2024 | 6814 | 0.120 |
Why?
|
| Immunohistochemistry | 21 | 2022 | 11073 | 0.120 |
Why?
|
| Lampreys | 2 | 1992 | 32 | 0.120 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 2 | 1985 | 93 | 0.120 |
Why?
|
| Postoperative Complications | 5 | 2021 | 15650 | 0.120 |
Why?
|
| Follow-Up Studies | 11 | 2021 | 39117 | 0.120 |
Why?
|
| Urinary Reservoirs, Continent | 1 | 2014 | 29 | 0.120 |
Why?
|
| Animals, Newborn | 9 | 1993 | 2677 | 0.110 |
Why?
|
| Urogenital Surgical Procedures | 1 | 2014 | 34 | 0.110 |
Why?
|
| Myelin Sheath | 3 | 1992 | 653 | 0.110 |
Why?
|
| Phenylthiohydantoin | 1 | 2015 | 205 | 0.110 |
Why?
|
| Dendrites | 4 | 1986 | 475 | 0.110 |
Why?
|
| Time Factors | 19 | 2020 | 39975 | 0.110 |
Why?
|
| Aged, 80 and over | 13 | 2024 | 58956 | 0.110 |
Why?
|
| Urinary Diversion | 1 | 2014 | 134 | 0.110 |
Why?
|
| Gliosis | 7 | 1991 | 244 | 0.110 |
Why?
|
| Lizards | 2 | 1990 | 50 | 0.110 |
Why?
|
| Ultrasonography | 4 | 2018 | 5970 | 0.110 |
Why?
|
| Afferent Pathways | 2 | 1991 | 298 | 0.110 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 1393 | 0.100 |
Why?
|
| Survival Rate | 6 | 2019 | 12720 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 1743 | 0.100 |
Why?
|
| Immunodiffusion | 12 | 1980 | 149 | 0.100 |
Why?
|
| Acrylamides | 2 | 1991 | 259 | 0.100 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1996 | 662 | 0.100 |
Why?
|
| Digestive System | 2 | 1991 | 244 | 0.100 |
Why?
|
| Purkinje Cells | 5 | 1987 | 226 | 0.100 |
Why?
|
| Cystoscopy | 2 | 2009 | 131 | 0.100 |
Why?
|
| Iris | 4 | 1985 | 232 | 0.100 |
Why?
|
| Spiral Ganglion | 3 | 1994 | 177 | 0.100 |
Why?
|
| Female | 51 | 2024 | 392581 | 0.100 |
Why?
|
| Prospective Studies | 8 | 2024 | 54415 | 0.090 |
Why?
|
| Wnt Proteins | 1 | 2015 | 718 | 0.090 |
Why?
|
| Cohort Studies | 7 | 2023 | 41446 | 0.090 |
Why?
|
| Urethral Neoplasms | 1 | 2011 | 37 | 0.090 |
Why?
|
| Radiation Injuries | 2 | 2016 | 1189 | 0.090 |
Why?
|
| Hippocampus | 7 | 1990 | 3763 | 0.090 |
Why?
|
| Aluminum | 3 | 1982 | 152 | 0.090 |
Why?
|
| Risk Assessment | 6 | 2021 | 23990 | 0.090 |
Why?
|
| Rabbits | 17 | 1990 | 4779 | 0.090 |
Why?
|
| Lymphangioma, Cystic | 1 | 2010 | 34 | 0.090 |
Why?
|
| Lymphangiectasis | 1 | 2010 | 20 | 0.090 |
Why?
|
| Carcinoma | 2 | 2017 | 2330 | 0.090 |
Why?
|
| Phosphorylation | 12 | 1995 | 8320 | 0.090 |
Why?
|
| Microscopy, Electron | 12 | 1993 | 2561 | 0.090 |
Why?
|
| Retroperitoneal Space | 1 | 2011 | 170 | 0.090 |
Why?
|
| Iron | 2 | 2009 | 1792 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 2 | 2016 | 1199 | 0.090 |
Why?
|
| Lymphatic Metastasis | 4 | 2011 | 2914 | 0.090 |
Why?
|
| Nervous System Diseases | 2 | 1994 | 1666 | 0.090 |
Why?
|
| Tumor Microenvironment | 4 | 2024 | 3874 | 0.080 |
Why?
|
| Polycythemia | 1 | 2010 | 125 | 0.080 |
Why?
|
| Risk Factors | 13 | 2024 | 74167 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1993 | 829 | 0.080 |
Why?
|
| Diaphragm | 1 | 1991 | 351 | 0.080 |
Why?
|
| Spinal Nerve Roots | 1 | 1989 | 121 | 0.080 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1990 | 345 | 0.080 |
Why?
|
| Embryo, Mammalian | 3 | 1992 | 1675 | 0.080 |
Why?
|
| Androgen Antagonists | 2 | 2015 | 1410 | 0.080 |
Why?
|
| Fishes | 4 | 1986 | 603 | 0.080 |
Why?
|
| Disease Progression | 3 | 2023 | 13502 | 0.080 |
Why?
|
| Species Specificity | 9 | 1992 | 2416 | 0.080 |
Why?
|
| Salvage Therapy | 3 | 2024 | 1264 | 0.080 |
Why?
|
| Antibodies | 12 | 1990 | 2421 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 2625 | 0.080 |
Why?
|
| Schwann Cells | 3 | 1985 | 197 | 0.080 |
Why?
|
| Cerebral Cortex | 11 | 1988 | 5776 | 0.080 |
Why?
|
| Urography | 1 | 2009 | 316 | 0.080 |
Why?
|
| Paraproteinemias | 1 | 2010 | 248 | 0.070 |
Why?
|
| Aging | 7 | 1990 | 8705 | 0.070 |
Why?
|
| Lymphatic Diseases | 1 | 2009 | 320 | 0.070 |
Why?
|
| Time Management | 1 | 2007 | 52 | 0.070 |
Why?
|
| Peptides | 7 | 1982 | 4345 | 0.070 |
Why?
|
| Cyanogen Bromide | 4 | 1984 | 73 | 0.070 |
Why?
|
| Olfactory Nerve | 1 | 1987 | 21 | 0.070 |
Why?
|
| Chick Embryo | 5 | 1992 | 982 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2005 | 12951 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2018 | 1913 | 0.070 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2011 | 549 | 0.070 |
Why?
|
| Membrane Glycoproteins | 4 | 2021 | 3702 | 0.070 |
Why?
|
| Immunochemistry | 8 | 1988 | 119 | 0.070 |
Why?
|
| Bronchi | 1 | 1991 | 845 | 0.070 |
Why?
|
| Treatment Failure | 2 | 2024 | 2642 | 0.070 |
Why?
|
| Preoperative Care | 3 | 2015 | 2242 | 0.070 |
Why?
|
| Trinucleotide Repeats | 2 | 1998 | 257 | 0.070 |
Why?
|
| Bucladesine | 2 | 1990 | 118 | 0.070 |
Why?
|
| Fibronectins | 6 | 1992 | 723 | 0.070 |
Why?
|
| Cells, Cultured | 24 | 1992 | 18964 | 0.070 |
Why?
|
| Scrapie | 1 | 1985 | 21 | 0.060 |
Why?
|
| Patient Care Planning | 1 | 2011 | 908 | 0.060 |
Why?
|
| Anemia | 1 | 2015 | 1508 | 0.060 |
Why?
|
| Astrocytoma | 3 | 1989 | 775 | 0.060 |
Why?
|
| Raphe Nuclei | 2 | 1986 | 103 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1990 | 894 | 0.060 |
Why?
|
| Urinary Fistula | 1 | 2005 | 42 | 0.060 |
Why?
|
| Cartilage | 1 | 1989 | 806 | 0.060 |
Why?
|
| Ileus | 1 | 2005 | 66 | 0.060 |
Why?
|
| Flank Pain | 1 | 2004 | 43 | 0.060 |
Why?
|
| Trachea | 1 | 1991 | 1089 | 0.060 |
Why?
|
| Nervous System | 2 | 1986 | 545 | 0.060 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1986 | 155 | 0.060 |
Why?
|
| Mesencephalon | 1 | 1986 | 332 | 0.060 |
Why?
|
| Obesity | 2 | 2012 | 12938 | 0.060 |
Why?
|
| Intraoperative Period | 1 | 2005 | 511 | 0.060 |
Why?
|
| Versicans | 2 | 1993 | 40 | 0.060 |
Why?
|
| Carcinoma, Small Cell | 1 | 1986 | 420 | 0.060 |
Why?
|
| Ganglia, Sympathetic | 3 | 1990 | 65 | 0.060 |
Why?
|
| Locus Coeruleus | 2 | 1984 | 230 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2014 | 1909 | 0.060 |
Why?
|
| Cell Aggregation | 4 | 1979 | 239 | 0.050 |
Why?
|
| Rectum | 1 | 2008 | 892 | 0.050 |
Why?
|
| Polylysine | 3 | 1992 | 131 | 0.050 |
Why?
|
| Neuroblastoma | 2 | 1984 | 1250 | 0.050 |
Why?
|
| Cell Differentiation | 16 | 1990 | 11526 | 0.050 |
Why?
|
| Staining and Labeling | 4 | 1991 | 1084 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 9418 | 0.050 |
Why?
|
| Autoantibodies | 3 | 1986 | 2124 | 0.050 |
Why?
|
| Tubulin | 6 | 1991 | 693 | 0.050 |
Why?
|
| Immunoelectrophoresis | 6 | 1977 | 104 | 0.050 |
Why?
|
| Phosphoproteins | 2 | 1988 | 2448 | 0.050 |
Why?
|
| Vinblastine | 3 | 1980 | 488 | 0.050 |
Why?
|
| Dogs | 6 | 1990 | 3839 | 0.050 |
Why?
|
| Tissue Distribution | 5 | 1990 | 2265 | 0.050 |
Why?
|
| Erectile Dysfunction | 1 | 2005 | 444 | 0.050 |
Why?
|
| Synapses | 2 | 1990 | 1769 | 0.050 |
Why?
|
| Colchicine | 2 | 1980 | 260 | 0.050 |
Why?
|
| ROC Curve | 2 | 2021 | 3580 | 0.050 |
Why?
|
| Collagen Type IV | 1 | 2021 | 126 | 0.050 |
Why?
|
| Culture Techniques | 3 | 1989 | 531 | 0.050 |
Why?
|
| Age Factors | 6 | 2020 | 18400 | 0.050 |
Why?
|
| Predictive Value of Tests | 4 | 2021 | 15262 | 0.050 |
Why?
|
| Operating Rooms | 1 | 2007 | 790 | 0.050 |
Why?
|
| Edema | 2 | 2018 | 767 | 0.040 |
Why?
|
| Mitosis | 1 | 1986 | 1187 | 0.040 |
Why?
|
| Chromatography, Ion Exchange | 5 | 1984 | 296 | 0.040 |
Why?
|
| Urinary Incontinence | 1 | 2005 | 489 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 5305 | 0.040 |
Why?
|
| Boston | 3 | 2019 | 9330 | 0.040 |
Why?
|
| Myelin Proteins | 1 | 1981 | 209 | 0.040 |
Why?
|
| Head-Down Tilt | 1 | 2019 | 65 | 0.040 |
Why?
|
| Neurotoxins | 2 | 1994 | 240 | 0.040 |
Why?
|
| Nitriles | 2 | 2015 | 971 | 0.040 |
Why?
|
| Capsaicin | 2 | 1991 | 231 | 0.040 |
Why?
|
| Multiple Sclerosis | 6 | 1989 | 3224 | 0.040 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1986 | 1491 | 0.040 |
Why?
|
| Testicular Neoplasms | 1 | 2005 | 799 | 0.040 |
Why?
|
| Mucins | 1 | 2022 | 568 | 0.040 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 2449 | 0.040 |
Why?
|
| Bone Neoplasms | 1 | 2011 | 2529 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2009 | 2977 | 0.040 |
Why?
|
| Muscle, Smooth | 3 | 2016 | 926 | 0.040 |
Why?
|
| Amyloid | 1 | 1984 | 841 | 0.040 |
Why?
|
| Polymorphism, Genetic | 3 | 1998 | 4287 | 0.040 |
Why?
|
| Lymph Node Excision | 1 | 2005 | 1271 | 0.040 |
Why?
|
| Cytoplasm | 2 | 1994 | 1511 | 0.040 |
Why?
|
| Image Enhancement | 1 | 2009 | 2884 | 0.040 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2019 | 120 | 0.040 |
Why?
|
| Chromatography, Affinity | 5 | 1984 | 532 | 0.040 |
Why?
|
| Glioma | 7 | 1989 | 3455 | 0.040 |
Why?
|
| Anterior Chamber | 2 | 1989 | 194 | 0.040 |
Why?
|
| HIV-1 | 1 | 1996 | 6860 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 1983 | 520 | 0.040 |
Why?
|
| Wounds, Penetrating | 2 | 1990 | 313 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2024 | 1330 | 0.040 |
Why?
|
| Contrast Media | 2 | 2009 | 5311 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2024 | 1090 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 1986 | 1994 | 0.040 |
Why?
|
| Mice | 24 | 2015 | 81509 | 0.040 |
Why?
|
| Alzheimer Disease | 3 | 1985 | 8596 | 0.040 |
Why?
|
| Dopamine | 2 | 1986 | 1605 | 0.040 |
Why?
|
| Testicular Diseases | 1 | 2018 | 73 | 0.040 |
Why?
|
| Brain Stem | 2 | 1981 | 858 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2009 | 3466 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2009 | 1955 | 0.040 |
Why?
|
| Hydrocephalus | 1 | 2004 | 764 | 0.040 |
Why?
|
| Decision Support Techniques | 1 | 2007 | 1998 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 3 | 1992 | 1974 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2024 | 2706 | 0.040 |
Why?
|
| Ferrosoferric Oxide | 2 | 2009 | 348 | 0.040 |
Why?
|
| Immunoglobulin G | 4 | 1985 | 4549 | 0.040 |
Why?
|
| Vincristine | 1 | 1980 | 1036 | 0.040 |
Why?
|
| Rats, Mutant Strains | 2 | 1989 | 60 | 0.040 |
Why?
|
| beta Catenin | 1 | 2022 | 1040 | 0.040 |
Why?
|
| Patient Positioning | 1 | 2019 | 326 | 0.030 |
Why?
|
| Keratins | 4 | 1986 | 497 | 0.030 |
Why?
|
| Immunoblotting | 2 | 1991 | 1647 | 0.030 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1977 | 126 | 0.030 |
Why?
|
| Myosins | 1 | 1978 | 405 | 0.030 |
Why?
|
| Cross Reactions | 6 | 1980 | 818 | 0.030 |
Why?
|
| Magnetite Nanoparticles | 2 | 2009 | 318 | 0.030 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 1997 | 74 | 0.030 |
Why?
|
| Pain, Postoperative | 2 | 2024 | 1737 | 0.030 |
Why?
|
| Dextrans | 2 | 2009 | 574 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 20556 | 0.030 |
Why?
|
| Organ of Corti | 2 | 1994 | 85 | 0.030 |
Why?
|
| Dogfish | 2 | 1986 | 11 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2021 | 1870 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 3 | 1985 | 127 | 0.030 |
Why?
|
| Pressure | 1 | 2019 | 1155 | 0.030 |
Why?
|
| Trout | 2 | 1986 | 20 | 0.030 |
Why?
|
| Organ Culture Techniques | 2 | 1993 | 794 | 0.030 |
Why?
|
| Serotonin | 1 | 1981 | 1042 | 0.030 |
Why?
|
| Orchiectomy | 1 | 2018 | 463 | 0.030 |
Why?
|
| Leukocyte Disorders | 1 | 2015 | 12 | 0.030 |
Why?
|
| Eye Injuries | 1 | 1979 | 227 | 0.030 |
Why?
|
| Frontal Lobe | 2 | 1982 | 1420 | 0.030 |
Why?
|
| Turtles | 3 | 1985 | 40 | 0.030 |
Why?
|
| Rats, Inbred F344 | 4 | 1986 | 826 | 0.030 |
Why?
|
| Propensity Score | 1 | 2023 | 1908 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 1560 | 0.030 |
Why?
|
| Proteins | 2 | 1981 | 6032 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2021 | 2613 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2007 | 3460 | 0.030 |
Why?
|
| Cyprinidae | 1 | 1974 | 37 | 0.030 |
Why?
|
| Mycobacterium | 1 | 1996 | 251 | 0.030 |
Why?
|
| Evoked Potentials | 3 | 1990 | 1037 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 1994 | 8179 | 0.030 |
Why?
|
| Acrylamide | 2 | 1991 | 59 | 0.030 |
Why?
|
| Fibroblasts | 2 | 1981 | 4140 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 1995 | 213 | 0.030 |
Why?
|
| Incidence | 4 | 2017 | 21341 | 0.030 |
Why?
|
| Case-Control Studies | 5 | 2018 | 22168 | 0.030 |
Why?
|
| Isoelectric Focusing | 3 | 1989 | 159 | 0.030 |
Why?
|
| Guinea Pigs | 8 | 1990 | 1317 | 0.030 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1993 | 141 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 2076 | 0.030 |
Why?
|
| Cell Division | 4 | 1990 | 4466 | 0.030 |
Why?
|
| Age of Onset | 1 | 2020 | 3304 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 1981 | 2498 | 0.030 |
Why?
|
| Immunosorbent Techniques | 2 | 1985 | 176 | 0.030 |
Why?
|
| Brain Neoplasms | 5 | 1989 | 9031 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 20093 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2015 | 552 | 0.030 |
Why?
|
| Heart Rate | 1 | 2024 | 4198 | 0.030 |
Why?
|
| Antigen-Antibody Reactions | 2 | 1986 | 346 | 0.030 |
Why?
|
| Stents | 1 | 2004 | 3179 | 0.030 |
Why?
|
| Ischemia | 1 | 2001 | 1877 | 0.030 |
Why?
|
| Rats, Nude | 2 | 1989 | 105 | 0.030 |
Why?
|
| Hospitals, General | 1 | 2017 | 798 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1997 | 1171 | 0.030 |
Why?
|
| Rana pipiens | 2 | 1985 | 64 | 0.020 |
Why?
|
| Cerebellar Cortex | 1 | 1973 | 107 | 0.020 |
Why?
|
| Recurrence | 1 | 2004 | 8469 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2016 | 1638 | 0.020 |
Why?
|
| Neoplasm Proteins | 2 | 1986 | 3612 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2021 | 6343 | 0.020 |
Why?
|
| Antigens, Surface | 2 | 1990 | 1609 | 0.020 |
Why?
|
| Amino Acid Sequence | 5 | 1995 | 13449 | 0.020 |
Why?
|
| Retinal Ganglion Cells | 2 | 1989 | 811 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2015 | 1596 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1995 | 655 | 0.020 |
Why?
|
| Vasoactive Intestinal Peptide | 3 | 1990 | 180 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 2803 | 0.020 |
Why?
|
| Cell Movement | 3 | 1991 | 5203 | 0.020 |
Why?
|
| Pyramidal Tracts | 1 | 1973 | 252 | 0.020 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 1990 | 58 | 0.020 |
Why?
|
| Neuropeptides | 2 | 1994 | 944 | 0.020 |
Why?
|
| Axonal Transport | 2 | 1989 | 178 | 0.020 |
Why?
|
| Amino Acids | 5 | 1981 | 1718 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 12456 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2015 | 918 | 0.020 |
Why?
|
| Neurites | 1 | 1992 | 391 | 0.020 |
Why?
|
| Ribs | 1 | 2012 | 252 | 0.020 |
Why?
|
| Proteoglycans | 1 | 1993 | 803 | 0.020 |
Why?
|
| Isoproterenol | 1 | 1990 | 395 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 1990 | 364 | 0.020 |
Why?
|
| Urinary Retention | 1 | 1991 | 106 | 0.020 |
Why?
|
| S100 Proteins | 3 | 1985 | 218 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 3447 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 1993 | 584 | 0.020 |
Why?
|
| Benzamides | 1 | 2015 | 1370 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3541 | 0.020 |
Why?
|
| Parietal Lobe | 2 | 1986 | 851 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2015 | 10089 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2021 | 3312 | 0.020 |
Why?
|
| Antibody Formation | 2 | 1992 | 1398 | 0.020 |
Why?
|
| Hydronephrosis | 1 | 2010 | 271 | 0.020 |
Why?
|
| Pineal Gland | 1 | 1990 | 158 | 0.020 |
Why?
|
| Ganglia | 2 | 1986 | 87 | 0.020 |
Why?
|
| Skin Neoplasms | 2 | 1986 | 5819 | 0.020 |
Why?
|
| Hexanones | 1 | 1988 | 5 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 2416 | 0.020 |
Why?
|
| Electric Stimulation | 2 | 1990 | 1736 | 0.020 |
Why?
|
| Models, Biological | 1 | 2024 | 9469 | 0.020 |
Why?
|
| Fetus | 3 | 1994 | 1864 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2012 | 1975 | 0.020 |
Why?
|
| Cochlea | 1 | 1994 | 845 | 0.020 |
Why?
|
| Sheep | 2 | 1985 | 1440 | 0.020 |
Why?
|
| HEPES | 1 | 1987 | 10 | 0.020 |
Why?
|
| Clone Cells | 2 | 1984 | 1659 | 0.020 |
Why?
|
| Dementia | 2 | 1982 | 2686 | 0.020 |
Why?
|
| Trypsin | 2 | 1986 | 496 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 2020 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2015 | 2611 | 0.020 |
Why?
|
| Skull | 1 | 2012 | 818 | 0.020 |
Why?
|
| Choristoma | 1 | 1989 | 206 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 14664 | 0.020 |
Why?
|
| Eye Neoplasms | 1 | 1989 | 307 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 3602 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2024 | 23441 | 0.020 |
Why?
|
| Ketones | 1 | 1988 | 184 | 0.020 |
Why?
|
| Hydroxydopamines | 1 | 1986 | 59 | 0.020 |
Why?
|
| Ethanolamines | 1 | 1987 | 153 | 0.020 |
Why?
|
| Eye | 1 | 1991 | 711 | 0.020 |
Why?
|
| Trigeminal Nerve | 2 | 1985 | 248 | 0.020 |
Why?
|
| Quinolinic Acids | 1 | 1986 | 15 | 0.020 |
Why?
|
| Tissue Extracts | 1 | 1987 | 141 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 2254 | 0.020 |
Why?
|
| Cell Adhesion | 4 | 1989 | 3087 | 0.020 |
Why?
|
| Spinal Cord Injuries | 1 | 1974 | 925 | 0.020 |
Why?
|
| Methylazoxymethanol Acetate | 1 | 1986 | 6 | 0.020 |
Why?
|
| Peptide Fragments | 4 | 1984 | 5115 | 0.020 |
Why?
|
| Mutation | 3 | 2024 | 30045 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 1990 | 7856 | 0.020 |
Why?
|
| Survivors | 1 | 2017 | 2371 | 0.020 |
Why?
|
| Bufonidae | 1 | 1985 | 12 | 0.020 |
Why?
|
| Electrophoresis, Disc | 2 | 1977 | 66 | 0.020 |
Why?
|
| Radiotherapy, Conformal | 1 | 2009 | 548 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 1989 | 607 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 13637 | 0.020 |
Why?
|
| Azo Compounds | 1 | 1986 | 117 | 0.020 |
Why?
|
| Urologic Diseases | 1 | 2008 | 247 | 0.020 |
Why?
|
| Brain Diseases | 1 | 1974 | 1545 | 0.020 |
Why?
|
| Oligodendroglia | 3 | 1981 | 538 | 0.020 |
Why?
|
| Pancreatic Polypeptide | 1 | 1985 | 34 | 0.020 |
Why?
|
| Isoelectric Point | 1 | 1985 | 76 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 1989 | 753 | 0.020 |
Why?
|
| Gestational Age | 4 | 1989 | 3576 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 1985 | 225 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1991 | 710 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2020 | 7956 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 8545 | 0.010 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2008 | 357 | 0.010 |
Why?
|
| Trigeminal Ganglion | 1 | 1985 | 190 | 0.010 |
Why?
|
| Pyridines | 2 | 1986 | 2875 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1993 | 2821 | 0.010 |
Why?
|
| Bronchial Neoplasms | 1 | 1984 | 110 | 0.010 |
Why?
|
| Congo Red | 1 | 1984 | 48 | 0.010 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1990 | 1164 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2016 | 9645 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2014 | 2597 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1986 | 412 | 0.010 |
Why?
|
| Kainic Acid | 1 | 1984 | 203 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1986 | 944 | 0.010 |
Why?
|
| Swine | 3 | 1995 | 5914 | 0.010 |
Why?
|
| Transplantation, Heterologous | 2 | 1989 | 2386 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1987 | 729 | 0.010 |
Why?
|
| tau Proteins | 1 | 1994 | 2095 | 0.010 |
Why?
|
| Pilot Projects | 2 | 2008 | 8633 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1984 | 664 | 0.010 |
Why?
|
| Bulbar Palsy, Progressive | 1 | 1983 | 9 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 12058 | 0.010 |
Why?
|
| Glycoproteins | 2 | 1983 | 2208 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 4510 | 0.010 |
Why?
|
| Lens, Crystalline | 1 | 1985 | 389 | 0.010 |
Why?
|
| Carbonic Anhydrases | 1 | 1983 | 108 | 0.010 |
Why?
|
| Ependymoma | 2 | 1983 | 320 | 0.010 |
Why?
|
| Carcinoid Tumor | 1 | 1984 | 224 | 0.010 |
Why?
|
| Tetanus Toxin | 1 | 1982 | 46 | 0.010 |
Why?
|
| Neutrophils | 1 | 2015 | 3766 | 0.010 |
Why?
|
| Tryptophan | 1 | 1984 | 482 | 0.010 |
Why?
|
| Sleep Stages | 1 | 1986 | 694 | 0.010 |
Why?
|
| Pyrrolidines | 1 | 1984 | 338 | 0.010 |
Why?
|
| Anencephaly | 1 | 1981 | 20 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1984 | 513 | 0.010 |
Why?
|
| Epidermis | 1 | 1985 | 527 | 0.010 |
Why?
|
| Ileum | 1 | 1984 | 557 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1986 | 13337 | 0.010 |
Why?
|
| Femoral Artery | 1 | 1986 | 827 | 0.010 |
Why?
|
| Pons | 1 | 1982 | 240 | 0.010 |
Why?
|
| Mesoderm | 1 | 1984 | 673 | 0.010 |
Why?
|
| Hair Cells, Auditory | 2 | 1994 | 381 | 0.010 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2007 | 1722 | 0.010 |
Why?
|
| Chondrosarcoma | 1 | 1983 | 296 | 0.010 |
Why?
|
| Bone Density Conservation Agents | 1 | 2008 | 795 | 0.010 |
Why?
|
| Arteries | 1 | 1986 | 1124 | 0.010 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 1986 | 952 | 0.010 |
Why?
|
| Nanostructures | 1 | 2005 | 551 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1986 | 1072 | 0.010 |
Why?
|
| Epithelium | 1 | 1985 | 1603 | 0.010 |
Why?
|
| Eye Diseases | 1 | 1986 | 654 | 0.010 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 1985 | 491 | 0.010 |
Why?
|
| Neoplasms, Nerve Tissue | 1 | 1980 | 21 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 2 | 1986 | 2645 | 0.010 |
Why?
|
| Chordoma | 1 | 1983 | 347 | 0.010 |
Why?
|
| Antigens | 2 | 1977 | 1446 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 1986 | 1173 | 0.010 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 1983 | 333 | 0.010 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2008 | 1520 | 0.010 |
Why?
|
| Cysteine | 1 | 1984 | 892 | 0.010 |
Why?
|
| Mass Screening | 1 | 2015 | 5428 | 0.010 |
Why?
|
| Spleen | 1 | 1986 | 2295 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1986 | 1205 | 0.010 |
Why?
|
| Amniotic Fluid | 1 | 1981 | 378 | 0.010 |
Why?
|
| Radiography | 1 | 2010 | 6966 | 0.010 |
Why?
|
| Wakefulness | 1 | 1986 | 1265 | 0.010 |
Why?
|
| Comorbidity | 1 | 2014 | 10498 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 16979 | 0.010 |
Why?
|
| Medulla Oblongata | 2 | 1978 | 248 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1983 | 1688 | 0.010 |
Why?
|
| Graft Survival | 1 | 1989 | 3819 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 2010 | 1924 | 0.010 |
Why?
|
| Aorta | 1 | 1986 | 2041 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2001 | 982 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1987 | 6215 | 0.010 |
Why?
|
| Cell Line | 3 | 1980 | 15605 | 0.010 |
Why?
|
| Optic Nerve Injuries | 1 | 1979 | 150 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 10203 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 2001 | 636 | 0.010 |
Why?
|
| Logistic Models | 1 | 2011 | 13255 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1985 | 3969 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2004 | 1165 | 0.010 |
Why?
|
| Neuropeptide Y | 2 | 1990 | 192 | 0.010 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 1998 | 247 | 0.010 |
Why?
|
| Pregnancy | 4 | 1992 | 29862 | 0.010 |
Why?
|
| Piperazines | 1 | 1987 | 2523 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 1997 | 195 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 3769 | 0.010 |
Why?
|
| United States | 2 | 2016 | 72339 | 0.010 |
Why?
|
| Denervation | 2 | 1987 | 265 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2006 | 4912 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1975 | 82 | 0.010 |
Why?
|
| Maturation-Promoting Factor | 1 | 1995 | 26 | 0.010 |
Why?
|
| Neural Pathways | 1 | 1986 | 3057 | 0.010 |
Why?
|
| Dansyl Compounds | 1 | 1974 | 20 | 0.010 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 1990 | 323 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1980 | 2116 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1997 | 783 | 0.010 |
Why?
|
| 4-Butyrolactone | 1 | 1995 | 61 | 0.010 |
Why?
|
| Densitometry | 1 | 1974 | 151 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1995 | 251 | 0.010 |
Why?
|
| Models, Molecular | 1 | 1984 | 5439 | 0.010 |
Why?
|
| Colorimetry | 1 | 1974 | 148 | 0.010 |
Why?
|
| Vestibulocochlear Nerve | 1 | 1994 | 115 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 1981 | 1265 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 1995 | 112 | 0.010 |
Why?
|
| Neurons, Efferent | 1 | 1994 | 81 | 0.010 |
Why?
|
| Phosphates | 1 | 1978 | 770 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1974 | 646 | 0.010 |
Why?
|
| Anura | 1 | 1973 | 80 | 0.010 |
Why?
|
| Goats | 1 | 1974 | 167 | 0.010 |
Why?
|
| Seizures | 1 | 1987 | 2957 | 0.010 |
Why?
|
| Chromatography | 1 | 1973 | 189 | 0.010 |
Why?
|
| Polyribosomes | 2 | 1984 | 109 | 0.010 |
Why?
|
| Phalloidine | 1 | 1993 | 21 | 0.010 |
Why?
|
| Microsomes | 2 | 1984 | 251 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1976 | 1435 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1986 | 2163 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 1986 | 2509 | 0.010 |
Why?
|
| Substantia Nigra | 2 | 1987 | 350 | 0.010 |
Why?
|
| Cats | 2 | 1985 | 975 | 0.010 |
Why?
|
| Cyclins | 1 | 1995 | 594 | 0.010 |
Why?
|
| Urea | 1 | 1974 | 444 | 0.010 |
Why?
|
| Homozygote | 1 | 1997 | 1796 | 0.010 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 1983 | 1469 | 0.010 |
Why?
|
| Actins | 1 | 1979 | 2050 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2001 | 2331 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1986 | 6626 | 0.010 |
Why?
|
| Autopsy | 1 | 1974 | 1007 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1995 | 1791 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2001 | 5246 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2006 | 6485 | 0.010 |
Why?
|
| Organ Specificity | 2 | 1985 | 1967 | 0.010 |
Why?
|
| Synaptophysin | 1 | 1990 | 139 | 0.010 |
Why?
|
| Gene Frequency | 1 | 1997 | 3647 | 0.010 |
Why?
|
| Androgens | 1 | 1997 | 1286 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1995 | 17644 | 0.010 |
Why?
|
| Polysaccharide-Lyases | 1 | 1989 | 47 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1974 | 709 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1989 | 283 | 0.010 |
Why?
|
| Microtubules | 1 | 1995 | 1074 | 0.000 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1990 | 370 | 0.000 |
Why?
|
| Corpus Striatum | 2 | 1986 | 1235 | 0.000 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 1990 | 263 | 0.000 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1989 | 1058 | 0.000 |
Why?
|
| Kinetics | 2 | 1989 | 6374 | 0.000 |
Why?
|
| Heparitin Sulfate | 1 | 1989 | 223 | 0.000 |
Why?
|
| Viscera | 1 | 1988 | 138 | 0.000 |
Why?
|
| Length of Stay | 1 | 2001 | 6422 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 6086 | 0.000 |
Why?
|
| Nomifensine | 1 | 1986 | 14 | 0.000 |
Why?
|
| Cytarabine | 1 | 1989 | 697 | 0.000 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1986 | 89 | 0.000 |
Why?
|
| Quinolinic Acid | 1 | 1986 | 67 | 0.000 |
Why?
|
| Oxidopamine | 1 | 1986 | 172 | 0.000 |
Why?
|
| Testosterone | 1 | 1997 | 2472 | 0.000 |
Why?
|
| Alleles | 1 | 1997 | 6922 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1986 | 213 | 0.000 |
Why?
|
| Globus Pallidus | 1 | 1987 | 250 | 0.000 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 1985 | 74 | 0.000 |
Why?
|
| Microinjections | 1 | 1986 | 321 | 0.000 |
Why?
|
| Digestive System Physiological Phenomena | 1 | 1985 | 15 | 0.000 |
Why?
|
| Biogenic Amines | 1 | 1984 | 53 | 0.000 |
Why?
|
| Collagen | 1 | 1993 | 2638 | 0.000 |
Why?
|
| Myenteric Plexus | 1 | 1984 | 49 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1995 | 3712 | 0.000 |
Why?
|
| Electrophoresis | 1 | 1984 | 234 | 0.000 |
Why?
|
| Adrenal Medulla | 1 | 1983 | 56 | 0.000 |
Why?
|
| Paraffin | 1 | 1983 | 37 | 0.000 |
Why?
|
| Desmosomes | 1 | 1983 | 72 | 0.000 |
Why?
|
| Monensin | 1 | 1983 | 30 | 0.000 |
Why?
|
| Mesentery | 1 | 1984 | 202 | 0.000 |
Why?
|
| Ciliary Body | 1 | 1984 | 167 | 0.000 |
Why?
|
| Cell Count | 1 | 1987 | 1835 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 3 | 1989 | 22163 | 0.000 |
Why?
|
| Nerve Growth Factors | 1 | 1985 | 563 | 0.000 |
Why?
|
| Genotype | 1 | 1997 | 13009 | 0.000 |
Why?
|
| Cell-Free System | 1 | 1982 | 340 | 0.000 |
Why?
|
| Esophagus | 1 | 1988 | 1031 | 0.000 |
Why?
|
| Intestine, Large | 1 | 1981 | 68 | 0.000 |
Why?
|
| Reticulocytes | 1 | 1982 | 289 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1990 | 1903 | 0.000 |
Why?
|
| Models, Neurological | 1 | 1990 | 1767 | 0.000 |
Why?
|
| Choroid | 1 | 1984 | 360 | 0.000 |
Why?
|
| Mice, Inbred Strains | 1 | 1984 | 1762 | 0.000 |
Why?
|
| Protein Precursors | 1 | 1985 | 1133 | 0.000 |
Why?
|
| Golgi Apparatus | 1 | 1983 | 405 | 0.000 |
Why?
|
| Culture Media | 1 | 1983 | 896 | 0.000 |
Why?
|
| Cell Communication | 1 | 1988 | 1657 | 0.000 |
Why?
|
| Electrophysiology | 1 | 1984 | 1262 | 0.000 |
Why?
|
| Hypothalamus | 1 | 1986 | 999 | 0.000 |
Why?
|
| Computers | 1 | 1983 | 594 | 0.000 |
Why?
|
| Capillaries | 1 | 1984 | 755 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1981 | 865 | 0.000 |
Why?
|
| Blood Vessels | 1 | 1986 | 1113 | 0.000 |
Why?
|
| Thalamus | 1 | 1987 | 1044 | 0.000 |
Why?
|
| Prevalence | 1 | 1997 | 15717 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1985 | 1771 | 0.000 |
Why?
|
| Biopolymers | 1 | 1979 | 184 | 0.000 |
Why?
|
| Intestines | 1 | 1988 | 1909 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1979 | 660 | 0.000 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 1978 | 37 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1986 | 3810 | 0.000 |
Why?
|
| Brain Injuries | 1 | 1990 | 2053 | 0.000 |
Why?
|
| Behavior, Animal | 1 | 1986 | 1878 | 0.000 |
Why?
|
| Solubility | 1 | 1979 | 1091 | 0.000 |
Why?
|
| Disulfides | 1 | 1979 | 465 | 0.000 |
Why?
|
| Cell Survival | 1 | 1987 | 5790 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1974 | 18247 | 0.000 |
Why?
|
| Medulloblastoma | 1 | 1980 | 678 | 0.000 |
Why?
|
| Temperature | 1 | 1979 | 2228 | 0.000 |
Why?
|
| Adolescent | 3 | 1984 | 88313 | 0.000 |
Why?
|
| Protein Binding | 1 | 1979 | 9352 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 1984 | 11902 | 0.000 |
Why?
|
| Glioblastoma | 1 | 1980 | 3482 | 0.000 |
Why?
|
| Macrophages | 1 | 1977 | 5768 | 0.000 |
Why?
|